|
|
May 19, 2020 –
Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG)
|
May 14, 2020 –
Points to consider when assessing relationships (or suspecting misattributed relationships) during family-based clinical genomic testing: a statement of the American College of Medical Genetics and Genomics (ACMG)
|
May 14, 2020 –
ACMG Updates Seminal Laboratory Standard on CFTR Variant Testing
|
May 14, 2020 –
CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG) (update of Watson et al. 2004, Richards et al. 2002, Grody et al. 2001)
|
|
|
May 11, 2020 –
Description/Summary - FROM Template
|
Apr 23, 2020 –
Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG)
|
Apr 21, 2020 –
Spinal Muscular Atrophy (SMA) ACT Sheet
|
Apr 21, 2020 –
Mucopolysaccharidosis Type 1 (MPS I) ACT Sheet
|
Apr 21, 2020 –
X-Linked Adrenoleukodystrophy (X-ALD) ACT Sheet
|
Apr 20, 2020 –
Aleksandar Rajkovic, MD, PhD, FACMG Is Elected to the ACMG Foundation for Genetic and Genomic Medicine Board of Directors
|
Apr 17, 2020 –
The ACMG Foundation for Genetic and Genomic Medicine Presents a Takeda/ACMG Foundation Next Generation Fellowship Award to Jasmine Knoll, MD
|
Apr 16, 2020 –
Diagnostic testing for uniparental disomy: a points to consider statement from the American College of Medical Genetics and Genomics (ACMG) (update of Shaffer et al. 2001)
|